David Place
10PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers.Fei Tang, Rebecca Kunder, Tom Chu
|Nov 12, 2021
Integrated stress response restricts macrophage necroptosis.David E Place, Parimal Samir, Rk Subbarao Malireddi
|Jun 19, 2021
TLR and IKK Complex-Mediated Innate Immune Signaling Inhibits Stress Granule Assembly.Parimal Samir, David E Place, R K Subbarao Malireddi
|May 05, 2021
Differential Immune Response Following Intranasal and Intradermal Infection with <i>Francisella tularensis:</i> Implications for Vaccine Development.McKayla J Nicol, David R Williamson, David E Place
|Apr 13, 2021
Intestinal tête-à-tête: helminths blunt immunity against flaviviruses.David E Place, Thirumala-Devi Kanneganti
|Jan 30, 2021
Metabolic regulation of pyroptotic cell death expands the therapeutic landscape for treating inflammatory disease.David E Place, Thirumala-Devi Kanneganti
Pageof 2
Frequent Collaborators
7 joint publications
Thirumala-Devi Kanneganti
3 joint publications
Parimal Samir
2 joint publications
Rajendra Karki
2 joint publications
R K Subbarao Malireddi
2 joint publications
Peter Vogel
1 joint publications
Benoit Briard
1 joint publications
Shelbi Christgen
1 joint publications
Bernard Henrissat
1 joint publications
Ravi C Kalathur
1 joint publications
Cam Robinson
